ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial designIgnace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon van Gorp, Debra Richardson, Michael McCarthySee the full list of authors
16 April 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
6 March 2024
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancerMario M Leitao,, Jr, Alexia Iasonos, Morgan Tomberlin, Lea A Moukarzel, Hannah Price, Gabrielle Bennetti, Bhavani Ramesh, Dennis S Chi, Kara Long Roche, Yukio Sonoda, Ahmed Al-Niami, Jennifer J Mueller, Ginger J Gardner, Vance BroachSee the full list of authors
21 March 2024
An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial)Luis Chiva, Pilar Ordás, Nerea Martin-Calvo, Jose Manuel Aramendia, Luisa Sanchez Lorenzo, Alejandro Gallego Martínez, Ángel Vizcay, Jose Angel Minguez, Nabil Manzour, Daniel Vázquez-Vicente, Enrique Chacon, Teresa Castellanos, Antonio Gonzalez Martin
13 March 2024
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese)Giorgia Dinoi, Vincenzo Tarantino, Nicolò Bizzarri, Emanuele Perrone, Ilaria Capasso, Diana Giannarelli, Denis Querleu, Maria Consiglia Giuliano, Anna Fagotti, Giovanni Scambia, Francesco Fanfani
7 February 2024
Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trialTingting Chen, Junfen Xu, Bairong Xia, Hui Wang, Yuanming Shen
30 December 2023
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trialFlorian Heitz, Christian Marth, Stéphanie Henry, Alexander Reuss, David Cibula, Lydia Gaba Garcia, Nicoletta Colombo, Barbara Schmalfeld, Nikolaus de Gregorio, Pauline Wimberger, Annette Hasenburg, Jalid Sehouli, Martina Gropp-Meier, Philip C Schouten, Eric HahnenSee the full list of authors
7 November 2023
PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trialMikko Loukovaara, Ralf Bützow, Synnöve Staff, Minna Mäenpää, Mária Faltinová, Heini Lassus, Olga Veijalainen, Maiju Grönvall, Leila Vaalavirta, Elina Kuikka, Marjut Haataja, Elina Urpilainen, Marja Simojoki, Maarit Anttila, Annika Auranen
9 October 2023
Side effects screening and early intervention to impact in quality of life of patients with gynecological cancers (HALIS study)Blanca Gil-Ibanez, Alvaro Tejerizo-Garcia, M Reyes Oliver, Ainhoa Madariaga, Maria Maiz Jimenez, Alejandra Gil Garcia, Gregorio Lopez-Gonzalez
24 September 2023
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancerRobert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Crafton, Erin Crane, Ramez Eskander, Sharad Ghamande, Whitney Graybill, Thomas HerzogSee the full list of authors
4 September 2023
